A newly-released report from Pharmaceutical Research and Manufacturers of America (PhRMA) has revealed that 28 new medications are in development to treat epilepsy and seizures.
But that’s just the tip of the iceberg.
These 28 new drugs are among nearly 420 new ground-breaking medicines in progress to treat neurological disorders.
Of the 28 epilepsy medicines listed in the report, seven are in or have completed phase one of development, eight are in or have completed phase two and, thirteen are in or have completed phase three.
The large number of drugs currently in clinical trials provides a measure of hope for patients whose epilepsy is not controlled with currently available medication.
In the future, this range of antiepileptic drugs will probably increase because of the use of new animal models, discovery of new basic mechanisms of epileptogenesis, acceleration of proof of principle studies in people, and development of new methods of drug delivery.
Other potential medicines – all in human clinical trials or under review by the Food and Drug Administration (FDA) – are diverse in scope.
62 for brain tumors – primary brain tumors are diagnosed each year in nearly 70,000 Americans…
82 medicines for Alzheimer’s disease, which afflicts more than 5 million Americans…
82 for pain – aiding adults who experience chronic pain, approximately 100 million Americans…
38 for multiple sclerosis, which afflicts an estimated 500,000 Americans…
27 for Parkinson’s Disease, affecting as many as 1.5 million Americans…
25 for headache, a condition that affects about 28 million Americans…
“Collaboration among all partners in the medical innovation ecosystem – including patients – is critical to help advance scientific understanding of some of the most complicated neurological disorders,” added PhRMA President and CEO John J. Castellani.
“Even with all the advancements made to date — and the hope provided in the pipeline — we have much to learn about how the human brain functions.
“Together, we can make it happen.”
NOTE: The BRAIN Initiative
The BRAIN Initiative aims to accelerate the development and application of new technologies to help researchers understand the inter-workings of the brain, leading to new ways to treat and maybe one day prevent or cure diseases, such as epilepsy Alzheimer’s and traumatic brain injury.
To subscribe to Epilepsy Talk and receive notifications of new posts by email, simply go to the bottom of the right column and click on where it says “Follow”